Edwards Lifesciences (EW) Profit After Tax Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.40% |
| Dec 31, 2025 | -22.40% |
| Sep 30, 2025 | -2.06% |
| Jun 30, 2025 | 36.39% |
| Mar 31, 2025 | 3.20% |
| Dec 31, 2024 | 6.52% |
| Sep 30, 2024 | 62.06% |
| Jun 30, 2024 | 8.54% |
| Mar 31, 2024 | 7.05% |
| Dec 31, 2023 | 116.52% |
| Sep 30, 2023 | 11.18% |
| Jun 30, 2023 | 1.67% |
| Mar 31, 2023 | 10.51% |
| Dec 31, 2022 | 136.26% |
| Sep 30, 2022 | 15.09% |
| Jun 30, 2022 | 16.91% |
| Mar 31, 2022 | 10.17% |
| Dec 31, 2021 | 16.17% |
| Sep 30, 2021 | 19.19% |
| Jun 30, 2021 | 31.06% |
| Mar 31, 2021 | 18.79% |
| Dec 31, 2020 | 17.08% |
| Sep 30, 2020 | 22.46% |
| Jun 30, 2020 | -25.24% |
| Mar 31, 2020 | 20.28% |
| Dec 31, 2019 | 20.74% |
| Sep 30, 2019 | 23.76% |
| Jun 30, 2019 | -15.03% |
| Mar 31, 2019 | 32.87% |
| Dec 31, 2018 | -37.79% |
| Sep 30, 2018 | 24.08% |
| Jun 30, 2018 | 24.82% |
| Mar 31, 2018 | 7.50% |
| Dec 31, 2017 | 55.36% |
| Sep 30, 2017 | 19.71% |
| Jun 30, 2017 | 22.38% |
| Mar 31, 2017 | 28.74% |
| Dec 31, 2016 | 24.54% |
| Sep 30, 2016 | 22.34% |
| Jun 30, 2016 | 16.86% |
| Mar 31, 2016 | 17.48% |
| Dec 31, 2015 | 16.77% |
| Sep 30, 2015 | 19.73% |
| Jun 30, 2015 | 14.41% |
| Mar 31, 2015 | 20.94% |
| Dec 31, 2014 | 18.07% |
| Sep 30, 2014 | 5.18% |
| Jun 30, 2014 | 63.03% |